Procore Technologies (NYSE:PCOR) versus BIO-key International (NASDAQ:BKYI) Critical Comparison

BIO-key International (NASDAQ:BKYI) and Procore Technologies (NYSE:PCOR) are both technology companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, profitability and dividends.

Risk and Volatility

BIO-key International has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500. Comparatively, Procore Technologies has a beta of 0.75, meaning that its stock price is 25% less volatile than the S&P 500.

Profitability

This table compares BIO-key International and Procore Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BIO-key International	-50.01%	-67.31%	-40.28%
Procore Technologies	-2.31%	2.67%	1.34%

Insider & Institutional Ownership

26.5% of BIO-key International shares are owned by institutional investors. Comparatively, 81.1% of Procore Technologies shares are owned by institutional investors. 4.0% of BIO-key International shares are owned by company insiders. Comparatively, 16.8% of Procore Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings for BIO-key International and Procore Technologies, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BIO-key International	1	1	0	0	1.50
Procore Technologies	1	2	18	0	2.81

Procore Technologies has a consensus price target of $80.35, indicating a potential upside of 3.59%. Given Procore Technologies’ stronger consensus rating and higher probable upside, analysts clearly believe Procore Technologies is more favorable than BIO-key International.

Earnings & Valuation

This table compares BIO-key International and Procore Technologies”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BIO-key International	$6.09 million	0.71	-$7.16 million	($4.11)	-0.52
Procore Technologies	$1.32 billion	8.77	-$100.78 million	($0.23)	-337.25

BIO-key International has higher earnings, but lower revenue than Procore Technologies. Procore Technologies is trading at a lower price-to-earnings ratio than BIO-key International, indicating that it is currently the more affordable of the two stocks.

Summary

Procore Technologies beats BIO-key International on 12 of the 14 factors compared between the two stocks.

About BIO-key International

BIO-key International, Inc. (NASDAQ: BKYI) develops biometric authentication and identity and access management solutions. The company helps organizations secure access to applications, networks, devices and data through fingerprint recognition and other authentication methods designed to reduce reliance on passwords. Its product portfolio includes PortalGuard, an identity and access management platform that supports single sign-on, multifactor authentication, self-service password management and access control.

About Procore Technologies

Procore Technologies provides cloud-based construction management software designed to help construction companies plan, manage and execute projects. Its platform connects project teams and stakeholders, including owners, general contractors, specialty contractors and design professionals. Procore’s products support project management, construction financials, workforce coordination, quality and safety processes, and project data and analytics. The platform also offers integrations with third-party applications to help customers connect construction workflows and business systems.